- Home
- TGL vs CNSP Comparison
TGL vs CNSP Comparison
Compare TGL & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- CNSP
- Stock Information
- Founded
- TGL 2020
- CNSP 2017
- Country
- TGL United States
- CNSP United States
- Employees
- TGL N/A
- CNSP N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- TGL Technology
- CNSP Health Care
- Exchange
- TGL Nasdaq
- CNSP Nasdaq
- Market Cap
- TGL 4.8M
- CNSP 5.6M
- IPO Year
- TGL 2022
- CNSP 2019
- Fundamental
- Price
- TGL $1.62
- CNSP $1.04
- Analyst Decision
- TGL
- CNSP Hold
- Analyst Count
- TGL 0
- CNSP 1
- Target Price
- TGL N/A
- CNSP N/A
- AVG Volume (30 Days)
- TGL 4.0M
- CNSP 4.9M
- Earning Date
- TGL 05-15-2025
- CNSP 06-17-2025
- Dividend Yield
- TGL N/A
- CNSP N/A
- EPS Growth
- TGL N/A
- CNSP N/A
- EPS
- TGL N/A
- CNSP N/A
- Revenue
- TGL $1,468,790.00
- CNSP N/A
- Revenue This Year
- TGL N/A
- CNSP N/A
- Revenue Next Year
- TGL N/A
- CNSP N/A
- P/E Ratio
- TGL N/A
- CNSP N/A
- Revenue Growth
- TGL N/A
- CNSP N/A
- 52 Week Low
- TGL $1.26
- CNSP $0.77
- 52 Week High
- TGL $203.50
- CNSP $414.00
- Technical
- Relative Strength Index (RSI)
- TGL 43.01
- CNSP 42.18
- Support Level
- TGL $1.38
- CNSP $1.00
- Resistance Level
- TGL $2.06
- CNSP $1.08
- Average True Range (ATR)
- TGL 0.20
- CNSP 0.09
- MACD
- TGL 0.08
- CNSP 0.00
- Stochastic Oscillator
- TGL 45.00
- CNSP 19.05
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.